Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
DNA-Demethylating Agents enhance cytolytic activity of CD8+ T Cells and anti-tumor immunity
EF 2017-18
Résumé
Recent studies have shown that DNA methyltransferase inhibitors (DNMTi) can induce IRF7 activation and Type I/III interferon signalling through dsRNA-mediated viral mimicry in cancer cells. By performing a large pan-cancer analysis using TCGA data, we determined that IRF7 activation is associated with higher CD8+ T cell tumor infiltration and higher cytolytic activity across multiple cancer types. Accordingly, we demonstrate that ex vivo and in vivo DNMTi treatment results in increased CD8+ T cell tumor infiltration, enhanced cytolytic activity and CD8+ T cell dependent tumor growth inhibition. Finally, we show that DNMTi triggers a process marked by the induction of viral mimicry directly on CD8+ T cells, leading to activation of dsRNA sensing pathway, downstream IRF7 activation and up-regulation of T cell activation markers, effector cytokines, and Granzyme B. Taken together, our findings suggest that IRF7 activation in the immune compartment, through pharmacological DNA demethylation to be a viable strategy for boosting anti-tumor immune response.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
377321
Name
Loo Yau Helen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
DNA-Demethylating Agents enhance cytolytic activity of CD8+ T Cells and anti-tumor immunity
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cancer Immunotherapy; Cd8 T Cells; Clinical Trial; Cytolytic Activity; Dna Methylation; Epigenetic Therapy; T Cell Biology
Abstract
Recent studies have shown that DNA methyltransferase inhibitors (DNMTi) can induce IRF7 activation and Type I/III interferon signalling through dsRNA-mediated viral mimicry in cancer cells. By performing a large pan-cancer analysis using TCGA data, we determined that IRF7 activation is associated with higher CD8+ T cell tumor infiltration and higher cytolytic activity across multiple cancer types. Accordingly, we demonstrate that ex vivo and in vivo DNMTi treatment results in increased CD8+ T cell tumor infiltration, enhanced cytolytic activity and CD8+ T cell dependent tumor growth inhibition. Finally, we show that DNMTi triggers a process marked by the induction of viral mimicry directly on CD8+ T cells, leading to activation of dsRNA sensing pathway, downstream IRF7 activation and up-regulation of T cell activation markers, effector cytokines, and Granzyme B. Taken together, our findings suggest that IRF7 activation in the immune compartment, through pharmacological DNA demethylation to be a viable strategy for boosting anti-tumor immune response.
Competitiondate
201711
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Loo Yau, Helen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~